Evidence map›Paper›PMID 33034708›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2021

3D kidney organoids for bench-to-bedside translation.

Navin Gupta, Emre Dilmen, Ryuji Morizane

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Potential Use of Organoids in Regenerative Medicine.Tissue engineering and regenerative medicine · 2024
    Review
  7. Progress and breakthroughs in human kidney organoid research.Biochemistry and biophysics reports · 2024
    Review
  8. Review
  9. Article
  10. Single-cell RNA sequencing and kidney organoid differentiation.Clinical and experimental nephrology · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Kidney organoids: a pioneering model for kidney diseases.Translational research : the journal of laboratory and clinical medicine · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Navin GuptaNephrology Division, Massachusetts General Hospital, Boston, MA, USA. ngupta12@bwh.harvard.edu.
Emre DilmenNephrology Division, Massachusetts General Hospital, Boston, MA, USA.
Ryuji MorizaneNephrology Division, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0377-5667
Harvard University · USMassachusetts General Hospital · US

Funding

Ex Vivo Generation of Functional Kidney Tissues for TransplantationUC2DK126023 · NIDDK · HARVARD UNIVERSITY · PI LEWIS, JENNIFER A. · 2020 to 2024
$4.0M
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model DiseaseUH3TR002155 · NCATS · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT, LEE, LUKE P. · 2019 to 2021
$3.3M
Recreating Kidney Organogenesis in vitro with Human Pluripotent Stem CellsDP2DK133821 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MORIZANE, RYUJI · 2019 to 2019
$2.5M
Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editingU01DK127587 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LEWIS, JENNIFER A., MORIZANE, RYUJI · 2020 to 2022
$2.1M
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model DiseaseUG3TR002155 · NCATS · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT, LEE, LUKE P. · 2017 to 2018
$2.0M
Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editingU01EB028899 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI LEWIS, JENNIFER A., MORIZANE, RYUJI · 2019 to 2019
$748k
Biomanufacturing of Vascularized Kidney Tissues: A Foundational Step towards Building a KidneyR56DK122380 · NIDDK · HARVARD UNIVERSITY · PI LEWIS, JENNIFER A. · 2019 to 2019
$530k
NCATS NIH HHS UG3 TR002155NCATS NIH HHS UH3 TR002155NIBIB NIH HHS DP2 EB029388NIBIB NIH HHS DP2EB029388NIBIB NIH HHS U01 EB028899NIBIB NIH HHS U01EB028899NIDDK NIH HHS DP2 DK133821NIDDK NIH HHS R56 DK122380NIDDK NIH HHS R56DK122380NIDDK NIH HHS U01 DK127587NIDDK NIH HHS UC2 DK126023
6 · The paper itself

Abstract

The kidneys are essential organs that filter the blood, removing urinary waste while maintaining fluid and electrolyte homeostasis. Current conventional research models such as static cell cultures and animal models are insufficient to grasp the complex human in vivo situation or lack translational value. To accelerate kidney research, novel research tools are required. Recent developments have allowed the directed differentiation of induced pluripotent stem cells to generate kidney organoids. Kidney organoids resemble the human kidney in vitro and can be applied in regenerative medicine and as developmental, toxicity, and disease models. Although current studies have shown great promise, challenges remain including the immaturity, limited reproducibility, and lack of perfusable vascular and collecting duct systems. This review gives an overview of our current understanding of nephrogenesis that enabled the generation of kidney organoids. Next, the potential applications of kidney organoids are discussed followed by future perspectives. This review proposes that advancement in kidney organoid research will be facilitated through our increasing knowledge on nephrogenesis and combining promising techniques such as organ-on-a-chip models.

Indexed as

AnimalsCell DifferentiationCell LineageCellular Reprogramming TechniquesForecastingHumansInduced Pluripotent Stem CellsKidneyKidney Tubules, CollectingMiceModels, AnimalNeovascularization, PhysiologicOrganogenesisOrganoidsRegenerative MedicineTranslational Research, BiomedicalBioengineeringKidney organoidNephronStem cells

Identifiers

PMID33034708
PMCPMC8026465
OpenAlexW3091779710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.